Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells

Journal of Histochemistry and Cytochemistry

Volumn 44, Issue 3, 1996, Pages 221-226

  Gown, A M ^a   Jiang, J J ^a   Matles, H ^a   Skelly, M ^a   Goodpaster, T ^a   Cass, L ^b   Reshatof, M ^b   Spaulding, D ^b   Coltrera, M D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

BrdU; Histone; In situ hybridization; S phase

Indexed keywords

ALCOHOL; ANTIGEN; BROXURIDINE; CYCLINE; DNA; FORMALDEHYDE; HISTONE H3; MESSENGER RNA; THYMIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DNA CONTENT; DNA REPLICATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029879464     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/44.3.8648081     Document Type: Article

References (44)

1. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007
2. Lipponen P, Papinaho S, Eskehnen M, Klemi PJ, Aaltomaa S, Kosma VM, Marin S, Syrjanen K. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer Anticancer Res 1992;12.1533
3. Kreipe H, Aim P, Olsson H, Hauberg M, Fischer L, Parwaresch R. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-Sl Am J Pathol 1993;142:651
4. Sitonen SM, Kallioniemi OP, Isola JJ. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancet. Am J Parhol 1993; 142:1081
5. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P. Proliferation index as a prognostic market in breast cancer. Cancer 1993;71:3926
6. Gasparini G, Boracchi P, Verderio P, Bevilacqua P. Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 1994,57.822
7. Nagashima T, DeArmond SJ, Murovic J, Hoshmo T. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 1985;67:155
8. Johnson HA, Rubini JR, Cronkite EP, Bond VP. Labeling of human tumor cells in vivo by tnriated rhymidine. Lab Invest 1960;9:460
9. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710
10. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology Histopathologv 1990;17:489
11. Kurki P, Ogata K, Tan EM Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immu nofluorescence microscopy and flow cytometry. J Immunol Methods 1988;109:49
12. Robbins BA, de la Vega D, Ogata K, Tan EM, Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987;111-841
13. Garcia RL, Colrreta MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 1989;134:733
14. Morris GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 1989;264:13856
15. Coltrera MD, Gown AM. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 1991;39:23
16. Bravo R, Macdonald-Bravo H Existence to two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987;105:1549
17. Hall PA, Levison DA, Woods AL, Yu CC. Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Wasseem NH, Lane DP Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162.285
18. Gerbaulet SP, van Wijnen AJ, Aronin N, Tassinari MS, Lian JB, Stein JL, Stein GS. Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgemcally derived calvarial osteoblast cultures. J Cell Biochem 1992,49:137
19. Morris TD, Weber LA, Mickey E, Stein GS, Stem JL. Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle Mol Cell Biol 1991;11:544
20. Bosch FX, Udvarhelyi N, Venter E, Herold-Mende C, Schuhmann A, Maier H. Weidauer H, Born AI. Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur J Cancer 1993;10:1454
21. Chou MY, Chang AL, McBnde J, Donoff B, Gallagher GT, Wong DT. A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol 1990; 136-729
22. Wong DT, Chou MY, Chang LC, Gallagher GT. Use of intracellular H3 messenger RNA as a marker to determine the proliferation pattern of normal and 7,12-dimethylbenz[a]amhracene-transformed hamster oral epithelium Cancer Res 1990;50:5107
23. Alison M, Chaudry Z, Baker J, Lauder I, Pringle H. Liver regeneration a comparison of in situ hybridization for histone mRNA with bromodeoxyuridine labeling for the detection of S-phase cells J Histochem Cytochem 1994,42:1603
24. Risio M. Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J Cell Biochem 1992;(suppl):79
25. Filderman AE, Silvestri GA, Gatsonis C, Luthringer DJ, Honig J, Flynn SD Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer Am Rev Respir Dis 1992,146.707
26. Clevenger CV, Epstein AL, Bauer KD. Modulation of the nuclear antigen p105 as a function of cell-cycle progression. J Cell Physiol 1987;130:336
27. Engstrom Y, Rozell B, Hansson HA, Stemme S, Thelander L Localization of ribonucleotide reductase in mammalian cells EMBO J 1984,3:863
28. Garrido MC, Cordell JL, Becker MH, Key G, Gerdes J, Jones M, Gatter KC, Mason DY Monoclonal antibody JC1: new reagent for studying cell proliferation J Clin Pathol 1992;45:860
29. Mauri FA, Girlando S, Palma PD, Buffa G, Perrone G, Doglione C, Kriepe H, Barbareschi M Ki-67 antibodies (Ki-55, MIB-1, Ki-67) in breast carcinomas: a brief quantitative comparison. Appl Immunohistochem 1994;2:171
30. Sampson SA, Kriepe H, Gillett CE, Smith P, Chaudary MA, Khan A, Wicks K, Parwaresch R, Barnes DM. KiS1-a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma [published erratum appears in J Pathol 1993:169:287]. J Pathol 1992;168:179
31. Tsutsumi Y, Hori S, Onoda N. DNA polymerase alpha. An immunohistochemical marker for proliferating cells in normal and neoplastic human tissues. Am J Clin Pathol 1990;93:643
32. Heck MM, Earnshaw WC. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 1986;103(6 pt 2):2569
33. Bravo R, Celis JE. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol 1980;84:795
34. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Im J Cancer 1983;31:13
35. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867
36. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357
37. Kamel OW, Franklin WA, Ringus JC, Meyer JS. Thymidine labeling index and Ki-67 growth faction in lesions of the breast. Am J Pathol 1989;134:107
38. Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D, Palestro G. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 1994;47:18
39. Linden MD, Ma CK, Kubus J, Brown RD, Zarbo RJ. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993;100:206
40. Takahashi T, Caviness VS Jr. PCNA-binding to DNA at the GI/S transition in proliferating cells of the developing cerebral wall. J Neurocytol 1993;22:1096
41. Tapscott SJ, Lassar AB, Davis RL, Weintraub H. 5-bromo-2′-deoxyuridine blocks myogenesis by extinguishing expression of MyoDI. Science 1989;245:532
42. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968;22:258
43. Hamilton E, Dobbin J. The validity of the labelling index in tumour studies. Br J Cancer 1985;51:15
44. Mitchell D, Ibrahim S, Gusterson BA. Improved immunohistochemical localization of tissue antigens using modified methacam fixation. J Histochem Cytochem 1985;33:491